Xylinas E - Search Results

1

Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Goubet AG, Lordello L, Alves Costa Silva C, Peguillet I, Gazzano M, Mbogning-Fonkou MD, Thelemaque C, Lebacle C, Thibault C, Audenet F, Pignot G, Gravis G, Helissey C, Campedel L, Roupret M, Xylinas E, Ouzaid I, Dubuisson A, Mazzenga M, Flament C, Ly P, Marty V, Signolle N, Sauvat A, Sbarrato T, Filahi M, Davin C, Haddad G, Bou Khalil J, Bleriot C, Danlos FX, Dunsmore G, Mulder K, Silvin A, Raoult T, Archambaud B, Belhechmi S, Gomperts Boneca I, Cayet N, Moya-Nilges M, Mallet A, Daillere R, Rouleau E, Radulescu C, Allory Y, Fieschi J, Rouanne M, Ginhoux F, Le Teuff G, Derosa L, Marabelle A, Van Dorp J, Van Dijk N, Van Der Heijden MS, Besse B, Andre F, Merad M, Kroemer G, Scoazec JY, Zitvogel L, Loriot Y. Goubet AG, et al. Among authors: xylinas e. Cancer Discov. 2022 Oct 5;12(10):2280-2307. doi: 10.1158/2159-8290.CD-22-0201. Cancer Discov. 2022. PMID: 35929803

2

Surgical resection for suburethral sling complications after treatment for stress urinary incontinence.

Misrai V, Rouprêt M, Xylinas E, Cour F, Vaessen C, Haertig A, Richard F, Chartier-Kastler E. Misrai V, et al. Among authors: xylinas e. J Urol. 2009 May;181(5):2198-202; discussion 2203. doi: 10.1016/j.juro.2009.01.036. Epub 2009 Mar 17. J Urol. 2009. PMID: 19296973

3

Is radical prostatectomy a viable therapeutic option in clinically locally advanced (cT3) prostate cancer?

Xylinas E, Daché A, Rouprêt M. Xylinas E, et al. BJU Int. 2010 Dec;106(11):1596-600. doi: 10.1111/j.1464-410X.2010.09630.x. Epub 2010 Sep 14. BJU Int. 2010. PMID: 20840545 Review.

4

Low pretreatment total testosterone (< 3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer.

Xylinas E, Ploussard G, Durand X, Fabre A, Salomon L, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A. Xylinas E, et al. BJU Int. 2011 May;107(9):1400-3. doi: 10.1111/j.1464-410X.2010.09816.x. Epub 2010 Nov 2. BJU Int. 2011. PMID: 21050360

5

Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors.

Alenda O, Ploussard G, Mouracade P, Xylinas E, de la Taille A, Allory Y, Vordos D, Hoznek A, Abbou CC, Salomon L. Alenda O, et al. Among authors: xylinas e. World J Urol. 2011 Oct;29(5):671-6. doi: 10.1007/s00345-010-0620-9. Epub 2010 Nov 24. World J Urol. 2011. PMID: 21107843

6

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.

Durand X, Xylinas E, Radulescu C, Haus-Cheymol R, Moutereau S, Ploussard G, Forgues A, Robert G, Vacherot F, Loric S, Allory Y, Ruffion A, de la Taille A. Durand X, et al. Among authors: xylinas e. BJU Int. 2012 Jul;110(1):43-9. doi: 10.1111/j.1464-410X.2011.10682.x. Epub 2012 Jan 5. BJU Int. 2012. PMID: 22221521

7

Anastomotic stricture after minimally invasive radical prostatectomy: what should be expected from the Van Velthoven single-knot running suture?

Ouzaid I, Xylinas E, Ploussard G, Hoznek A, Vordos D, Abbou CC, de la Taille A, Salomon L. Ouzaid I, et al. Among authors: xylinas e. J Endourol. 2012 Aug;26(8):1020-5. doi: 10.1089/end.2011.0650. Epub 2012 May 8. J Endourol. 2012. PMID: 22486229 Clinical Trial.

8

Laparoscopic partial nephrectomy: is it worth still performing the retroperitoneal route?

Ouzaid I, Xylinas E, Pignot G, Tardieu A, Hoznek A, Abbou CC, de la Taille A, Salomon L. Ouzaid I, et al. Among authors: xylinas e. Adv Urol. 2012;2012:473457. doi: 10.1155/2012/473457. Epub 2012 Jun 12. Adv Urol. 2012. PMID: 22754565 Free PMC article.

9

Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.

Campeggi A, Xylinas E, Ploussard G, Ouzaid I, Fabre A, Allory Y, Vordos D, Abbou CC, Salomon L, de la Taille A. Campeggi A, et al. Among authors: xylinas e. Urology. 2012 Sep;80(3):576-84. doi: 10.1016/j.urology.2012.04.066. Urology. 2012. PMID: 22925233

10

Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.

Xylinas E, Kluth L, Mangal S, Roupret M, Karakiewicz PI, Shariat SF. Xylinas E, et al. World J Urol. 2013 Feb;31(1):31-6. doi: 10.1007/s00345-012-0947-5. Epub 2012 Sep 18. World J Urol. 2013. PMID: 22986907 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters